The Postdischarge Risk of Venous Thromboembolism after Hip Replacement. The Role of Prolonged Prophylaxis

Drugs

Volumn 52, Issue SUPPL. 7, 1996, Pages 55-59

  Bergqvist, David ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ELECTIVE SURGERY; FEMALE; HEALTH CARE NEED; HEMATOMA; HIP ARTHROPLASTY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE THROMBOSIS; RANDOMIZED CONTROLLED TRIAL; VEIN BLOOD FLOW; VEIN INJURY;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HIP PROSTHESIS; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOEMBOLISM;

EID: 0030466042     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199600527-00010     Document Type: Article

References (47)

1. Stamatakis JD, Kakkar VV, Sagar S, et al. Femoral vein thrombosis and total hip replacement. BMJ 1997; 2: 223-5
2. Johnson R, Carmichael J, Almond H. Deep venous thrombosis following Charnley arthroplasty. Clin Orthop 1978; 132: 24-30
3. Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis: a venographic and necropsy study. J Bone Joint Surg 1990; 72B: 9-13
4. Lassen MR, Borris LC, Christiansen HM, et al. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand 1991; 62: 33-8
5. Kälebo P, Anthmyr BA, Eriksson BI, et al. Phlebographic findings in venous thrombosis following total hip replacement. Acta Radiol 1990; 31: 259-63
6. Modig J. Studies on the aetiology and nature of the pulmonary and circulatory reactions during total hip replacement. Acta Univers Upsal 1975: thesis no. 223: 1-79
7. Francis CW, Mardet V, Evarts CM. Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prosthesis. Lancet 1986; 1: 769
8. Bredbacka S, Andreen M, Blombäck M, et al. Activation of cascade systems by hip arthroplasty. No difference between fixation with and without cement. Acta Orthop Scand 1987; 58: 231-5
9. McNally MA, Mollan RAB. Total hip replacement, lower limb blood flow and venous thrombogenesis. J Bone Joint Surg 1993; 75B: 640-4
10. Comerota A, Stewart GJ, Alburger PD, et al. Operative venodilation: a previously unsuspected factor in the course of postoperative deep vein thrombosis. Surgery 1989; 106: 301-9
11. Sevitt S, Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet 1959; 11: 981
12. Bergqvist D, Lindblad B. A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 1985; 72: 105-8
13. Lindblad B, Eriksson MS, Bergqvist D. Autopsy verified pulmonary embolism at a surgical department. An analysis of the period 1951-1988. Br J Surg 1991; 78: 849-52
14. Bergqvist D, Fredin H. Pulmonary embolism and mortality in patients with fractured hips - a prospective consecutive series. Eur J Surg 1991; 157: 571-4
15. Huber O, Bounameaux H, Borst F, et al. Postoperative pulmonary embolism after hospital discharge. Arch Surg 1992; 127: 310-3
16. Schrøder H, Andreassen M. Autopsy-verified major pulmonary embolism after hip fracture. Clin Orthop Rel Res 1993; 293: 196-203
17. Nicolaides AN, Gordon-Smith I. A rational approach to prevention. In: Nicolaides AW, editor. Thromboembolism. Aetiology, advances in prevention and management. Lancaster: MTP, 1975: 205-25
18. Kakkar VV, Howe CT, Flanc C, et al. Natural history of postoperative deep-vein thrombosis. Lancet 1969; 11: 230-3
19. Schaub N, Duckert F, Fridrich R, et al. Häufigkeit postoperativer tiefer Venenthrombosen bei Patienten der Allgemeinen Chirurgie und Urologie Eine Untersuchung mit dem 125J-Fibrinogentest bei 95 Patienten ohne medikamentose Prophylaxe. Langenbecks Arch Chir 1975; 340: 23-34
20. Bergqvist D. Review of clinical trials of low molecular weight heparins. Eur J Surg 1992; 158: 67-78
21. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight heparin versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259-65
22. Hampson WG, Harris FC, Lucas HK, et al. Failure of low-dose heparin to prevent deep-vein thrombosis after hip replacement arthroplasty. Lancet 1974; II: 795-7
23. Mannucci PM, Citerio LE, Panajotopoulos N. Low-dose heparin and deep-vein thrombosis after total hip replacement. Thromb Haemost 1976; 36: 157-64
24. 125I-fibrinogen test. Acta Orthop Scand 1976; 47: 549-57
25. Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after hip replacement. J Bone Joint Surg 1981; 63B: 171
26. Johnson R, Green JR, Charnley J. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop 1977; 127: 123-32
27. Bergqvist D, Arnadottir M, Bergentz S-E, et al. Juvenile diabetes mellitus as a risk factor for postoperative venous thromboembolism. Acta Med Scand 1985; 217: 307-8
28. Scurr JH, Coleridge-Smith PD, Hasty JH. Regimen for improved effectiveness of intermittent pneumatic compression in deep venous thrombosis prophylaxis. Surgery 1987; 102: 816-20
29. Sørensen C, Andersen M, Kristiansen V, et al. Development of late thromboembolic complications after major elective abdominal surgery: an interim report. Thromb Haemost 1989; 62: 129
30. Trowbridge A, Boese CK, Woodruff B, et al. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. Clin Orthopaed 1994; 299: 203-8
31. Tremaine JD, Choroszky CH, Menking SA. Deep vein thrombosis in total hip arthroplasty patients. J Vasc Technol 1992; 16: 23-7
32. Lotke PA, Steinberg ME, Malcolm L, et al. Significance of deep venous thrombosis in the lower extremity after total joint arthroplasty. Clin Orthopaed 1994; 299: 25-30
33. Nicolaides A, Arcelus J, Belcaro G, et al. Prevention of venous thromboembolism. European Consensus Statement. Int Angiol 1992; 11: 151-9
34. Leizorovicz A, Haugh MC, Chapuis F-R, et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-20
35. Nurmohamed M, Rosendal F, Büller H, et al. Low molecular weight heparin versus standard heparin in general and orthopedic surgery. A meta-analysis. Lancet 1992; 340: 152-6
36. Mohr DN, Silverstein MD, Murtaugh PA, et al. Prophylactic agents for venous thrombosis in elective hip surgery. Arch Intern Med 1993; 153: 2221-8
37. Jorgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704
38. Planes A, Vochelle N, Mazs F, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10
39. Leyvraz PF, Bachmann F, Hoek J, et al. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ 1991; 303: 543-8
40. Eriksson BI, Zachrisson BE, Teger-Nilsson AC, et al. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988; 75: 1053-7
41. Bergqvist D, Benoni G, Björgell O, et al. Low-molecular weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700
42. Dahl OE, Andreassen G, Müller C, et al. The effect of prolonged thromboprophylaxis with dalteparin on the frequency of deep vein thrombosis (DVT) and pulmonary embolism (PE) 35 days after hip replacement surgery (HRS). Thromb Haemost 1995; 73: 1094
43. Lassen MR, Borris LC, on behalf of the Danish Prolonged Prophylaxis Study Group. Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty - a placebo-controlled study. Thromb Haemost 1995; 73: 1104
44. Planes A, Vochelle N, Darmon J-V, et al. Efficacy and safety of post-discharge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement: a prospective randomised double-blind placebo-controlled trial. Drugs 1996; 52 Suppl. 7: 47-54
45. Nylander G. Phlebographic diagnosis of acute deep leg thrombosis. Acta Chir Scand 1967; 30 Suppl. 387: 30-4
46. Zagrodnik J, Kaufner HK. Ambulante Thromboembolieprophylaxe in der Tramatologie durch Selbstinjektion von Heparin. Unfallchirurg 1990; 92: 331-3
47. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg 1995; 77-B: 6-10